The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
Keryx Biopharmaceuticals Inc. (KERX)

Keryx Biopharmaceuticals is a biopharmaceutical company focused on bringing therapies to market for patients with renal disease. Co.'s first product, Auryxia™ (ferric citrate), an oral, absorbable iron-based compound, received marketing approval from the U.S. Food and Drug Administration, or FDA, for the control of serum phosphorus levels in patients with chronic kidney disease, or CKD, on dialysis. Co. also has initiated a pivotal Phase three study of Auryxia for the treatment of iron deficiency anemia in patients with Stage 3 to 5 dialysis and non-dialysis dependent CKD.

KERX SEC Filing Email Alerts Service

Company Name:  Keryx Biopharmaceuticals Inc.
Sector:  Biotechnology
Number of ETFs Holding KERX:  11
Total Market Value Held by ETFs:  $45.89M
Total Market Capitalization:  $578.00M
% of Market Cap. Held by ETFs:  7.94%
November 28, 2015    5:00 PM Eastern

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Buy (3.11 out of 4)
50th percentile
(ranked higher than approx. 50% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Keryx Biopharmaceuticals Inc. (KERX) Page | The Online Investor | | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.